Benitec Biopharma Ltd ADR (BNTC) insider buying
7 open-market purchases of BNTC by Benitec Biopharma Ltd ADR's executives and directors since November 2025, worth $22M in total, from SEC Form 4 filings.
The most recent: Suvretta Capital Management, L bought $1M on December 29, 2025.
The biggest buyer over the period is Suvretta Capital Management, L: 7 purchases, $22M.
By year
| Year | Purchases | Value |
|---|---|---|
| 2025 | 7 | $22M |
Biggest buyers
| Insider | Buys | Value |
|---|---|---|
| Suvretta Capital Management, L | 7 | $22M |
Every purchase
Newest first. From SEC Form 4 filings. Insider buying across the market.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Dec 29, 2025 | Suvretta Capital Management, L |
77,387 | $13.44 | $1M | Form 4 |
| Dec 26, 2025 | Suvretta Capital Management, L |
16,836 | $13.10 | $220,552 | Form 4 |
| Dec 23, 2025 | Suvretta Capital Management, L |
50,000 | $12.85 | $642,500 | Form 4 |
| Dec 22, 2025 | Suvretta Capital Management, L |
19,542 | $12.08 | $236,067 | Form 4 |
| Dec 19, 2025 | Suvretta Capital Management, L |
16,384 | $11.48 | $188,088 | Form 4 |
| Dec 18, 2025 | Suvretta Capital Management, L |
10,215 | $11.24 | $114,817 | Form 4 |
| Nov 7, 2025 | Suvretta Capital Management, L |
1,481,481 | $13.50 | $20M | Form 4 |
Questions
Are Benitec Biopharma Ltd ADR insiders buying the stock?
7 open-market purchases of BNTC by Benitec Biopharma Ltd ADR's executives and directors since November 2025, worth $22M in total, from SEC Form 4 filings. The most recent: Suvretta Capital Management, L bought $1M on December 29, 2025.
What counts as insider buying here?
Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.
From Benitec Biopharma Ltd ADR's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.